Nuvectis Pharma Inc. (NVCT)
NVCT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$18.15
-7.82% on the day
Market cap
$591.9M
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | NVCT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001875558 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3 | S-3 | 2026-08-21 |
| Latest annual report | 10-K | 2026-02-11 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report FORM 8-K | 8-K | 2026-08-21 |
| Latest proxy | DEFA14A | 2026-04-27 |
Source: SEC EDGAR submissions feed, 273 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -10.4% |
| 1 month | -17.1% |
| 3 months | -2.3% |
| Year to date | +140.7% |
| 1 year | +193.6% |
| From 52-week high | -36.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CLYM | Climb Bio Inc. | $10.31 | -4.80% | $592.2M |
| IRWD | Ironwood Pharmaceuticals Inc. | $3.59 | -4.52% | $593.2M |
| AQST | Aquestive Therapeutics Inc. | $4.67 | -2.91% | $586.1M |
| CRMD | CorMedix Inc. | $7.39 | -0.94% | $576.0M |
| DSGN | Design Therapeutics Inc. | $9.78 | -10.36% | $612.0M |
| OLMA | Olema Pharmaceuticals Inc. | $7.02 | -4.62% | $614.2M |
| ZVRA | Zevra Therapeutics Inc. | $10.39 | -8.22% | $617.0M |
| WVE | Wave Life Sciences Inc. | $3.14 | -4.27% | $618.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier